Lamprene (clofazimine)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) July 2016 PLR Conversion; refer to label. CONTRAINDICATIONS (addition) LAMPRENE is contraindicated in patients with known...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts